Skip to content Skip to footer
Subscribe Now
Viewpoints_Erika Ross
VIEWPOINTS

Erika Ross, Director of Clinical & Applied Research at Abbott Shares Insights on FDA Breakthrough Device Designation to Explore its DBS System to Treat Treatment-Resistant Depression

Shots: Erika spoke about the FDA Breakthrough Device Designation received by Abbott to investigate its deep brain stimulation (DBS) system to treat treatment-resistant depression (TRD)Erika also talked about how NeuroSphere Virtual Clinic is compatible with the  deep brain stimulation (DBS) system The interview gives an understanding of Abbott’s vision to bring life-changing technologies in…
October 5, 2022

Read more

Viewpoints_Dr. Drew Falconer
VIEWPOINTS

PharmaShots Interview: Dr. Drew Falconer Shares Insights on the Abbott’s NeuroSphere Virtual Clinic

In an interview with PharmaShots, Dr. Drew Falconer, Neurologist and Director at Inova Parkinson's and Movement Disorders Center in Fairfax, Va. shares insights on the first neurostimulation technology in the US that allows patients to receive treatment from the doctor without leaving home.Shots:Abbott launches NeuroSphere Virtual Clinic that allows patients to communicate with their physicians,…
May 3, 2021

Read more